| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aspirin may lower risk of pancreatic cancer
|
Hitt, Emma
|
|
2002
|
3 |
9 |
p. 518-
1 p.
|
artikel
|
| 2 |
3-Bromopyruvate kills cancer cells in animals
|
Nelson, Kathleen
|
|
2002
|
3 |
9 |
p. 524-
1 p.
|
artikel
|
| 3 |
Changes needed for improved cancer care in the developing world
|
Chaturvedi, P
|
|
2002
|
3 |
9 |
p. 526-527
2 p.
|
artikel
|
| 4 |
3D conformal radiotherapy is safer than a brachytherapy–external-beam combination
|
Carlson, Robert H
|
|
2002
|
3 |
9 |
p. 519-
1 p.
|
artikel
|
| 5 |
Endostatin imaging to help understanding of antiangiogenic drugs
|
Barthel, Henryk
|
|
2002
|
3 |
9 |
p. 520-
1 p.
|
artikel
|
| 6 |
Erythropoietin improves quality of life—a response
|
Bottomley, Andrew
|
|
2002
|
3 |
9 |
p. 527-
1 p.
|
artikel
|
| 7 |
Gastric tumours may soon be treatable with a vaccine
|
Ahmad, Khabir
|
|
2002
|
3 |
9 |
p. 519-
1 p.
|
artikel
|
| 8 |
Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models
|
Hoffman, Robert M
|
|
2002
|
3 |
9 |
p. 546-556
11 p.
|
artikel
|
| 9 |
Gutkha banned in Indian states
|
Pai, Sanjay A
|
|
2002
|
3 |
9 |
p. 521-
1 p.
|
artikel
|
| 10 |
How good is cost–benefit assessment of phase II cancer trials?
|
Bradbury, Jane
|
|
2002
|
3 |
9 |
p. 524-
1 p.
|
artikel
|
| 11 |
Huntington's disease provides cancer clues
|
Kerr, Cathel
|
|
2002
|
3 |
9 |
p. 518-
1 p.
|
artikel
|
| 12 |
Morphine stimulates tumour growth
|
Bonn, Dorothy
|
|
2002
|
3 |
9 |
p. 520-
1 p.
|
artikel
|
| 13 |
Natural Killer T cells
|
van der Vliet, Hans JJ
|
|
2002
|
3 |
9 |
p. 574-
1 p.
|
artikel
|
| 14 |
New targets identified for preventing cognitive decline after cranial irradiation
|
Bradbury, Jane
|
|
2002
|
3 |
9 |
p. 521-
1 p.
|
artikel
|
| 15 |
Overhauling the breast cancer overview: are subsets subversive?
|
Coates, Alan S
|
|
2002
|
3 |
9 |
p. 525-526
2 p.
|
artikel
|
| 16 |
Overweight, obesity, and cancer risk
|
Bianchini, Franca
|
|
2002
|
3 |
9 |
p. 565-574
10 p.
|
artikel
|
| 17 |
Part I: Chemotherapy for epithelial ovarian cancer–treatment at first diagnosis
|
Harries, Mark
|
|
2002
|
3 |
9 |
p. 529-536
8 p.
|
artikel
|
| 18 |
Part II: Chemotherapy for epithelial ovarian cancer-treatment of rcurrent disease
|
Harries, Mark
|
|
2002
|
3 |
9 |
p. 537-545
9 p.
|
artikel
|
| 19 |
Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care
|
Gupta, Tejpal
|
|
2002
|
3 |
9 |
p. 557-564
8 p.
|
artikel
|
| 20 |
Promising results in stomach cancer trial
|
Kerr, Cathel
|
|
2002
|
3 |
9 |
p. 523-
1 p.
|
artikel
|
| 21 |
Survivors of lung cancer have good quality of life
|
Boughton, Barbara
|
|
2002
|
3 |
9 |
p. 522-
1 p.
|
artikel
|
| 22 |
The price of anticancer intervention
|
Ganz, Patricia A
|
|
2002
|
3 |
9 |
p. 575-579
5 p.
|
artikel
|
| 23 |
Thyroid cancer in a child born after the Chernobyl disaster
|
Marks, Seth
|
|
2002
|
3 |
9 |
p. 527-528
2 p.
|
artikel
|
| 24 |
Urine test for bladder cancer
|
Burton, Adrian
|
|
2002
|
3 |
9 |
p. 522-
1 p.
|
artikel
|
| 25 |
Vaccination with varicella protects against zoster infection
|
Ahmad, Khabir
|
|
2002
|
3 |
9 |
p. 523-
1 p.
|
artikel
|
| 26 |
What is clinical research for?
|
Lee, John A
|
|
2002
|
3 |
9 |
p. 580-
1 p.
|
artikel
|
| 27 |
You are what you eat
|
The Lancet Oncology,
|
|
2002
|
3 |
9 |
p. 517-
1 p.
|
artikel
|
Tijdschrift beschrijving